Recombinant Human SPLUNC3 Protein，His

SPLUNC3, a member of the sapien family of proteins, has garnered increasing attention in the field of biomedical research due to its potential role in innate immunity and respiratory health. Initially identified in the human airway epithelium, SPLUNC3 exhibits antibacterial properties and may play a critical role in mucosal defense mechanisms. Its expression is primarily localized in the respiratory tract and associated tissues, suggesting it may be involved in protecting these vital areas from microbial infections and inflammation. Recent studies have indicated that SPLUNC3 might influence airway surface liquid composition and mucociliary clearance, which are essential for maintaining respiratory hygiene. Moreover, alterations in SPLUNC3 levels have been linked to various respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD), prompting investigations into its therapeutic potential. The recombinant production of SPLUNC3 provides a valuable tool for understanding its biological functions, structure-function relationships, and its mechanisms in disease processes. By studying SPLUNC3 through recombinant protein techniques, researchers aim to elucidate its interactions with pathogens and other immune components, which may pave the way for novel therapeutic strategies targeting respiratory conditions. With ongoing research, SPLUNC3 holds promise not only as a biomarker but also as a potential therapeutic agent in enhancing respiratory health and combating related diseases.